The US is way behind other countries when it comes to sunscreen, thanks to a backlog at the FDA, reports Time. For more than a decade, key ingredients used all over the world have been held up in the US waiting for government approval. Even 2002 legislation aimed at speeding the process hasn't resulted in the ingredients' approval in over-the-counter sunscreens. A new congressional effort, however, could put us on even ground with Europe, Asia, and Central and South America, reports the National Journal.
This week, a House Energy and Commerce subcommittee moved forward with the Sunscreen Innovation Act, aimed at easing the path of approval for ingredients—especially those that have been in use in other countries. Among other things, it would require the FDA to make a decision on existing applications within eight months and new ones within a year, reports the Hill. It's likely to pass the full House in a matter of weeks and then be taken up by the Senate. Given that skin cancer is the most common form of cancer in the US, supporters say it's long overdue.